SEC Form 4 · accession 0001658613-15-000002
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Edward McKechnie
Director
Period of report
Sep 16, 2015
Accepted (ET)
Nov 23, 2015 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Sep 16, 2015 | P | 100,000 | $0.19 | A | 100,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.19 | holding | — | — | — | Sep 16, 2015 | Sep 16, 2020 | Common Shares | 100,000 | 100,000 | D |